CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
4.24 NOK
-0.1 (-2.3%)
Overall CONTX gets a fundamental rating of 5 out of 10. We evaluated CONTX against 10 industry peers in the Health Care Technology industry. CONTX has an excellent profitability rating, but there are some minor concerns on its financial health. CONTX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CONTX had positive earnings in the past year.
CONTX had a positive operating cash flow in the past year.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
CONTX has a Return On Assets (7.66%) which is comparable to the rest of the industry.
CONTX has a Return On Equity (10.25%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 8.96%, CONTX is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 9.28%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(8.96%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX's Profit Margin of 7.86% is in line compared to the rest of the industry. CONTX outperforms 60.00% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
CONTX has a Operating Margin of 9.33%. This is comparable to the rest of the industry: CONTX outperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of CONTX has grown nicely.
The Gross Margin of CONTX (97.46%) is better than 90.00% of its industry peers.
In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
CONTX has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, CONTX has a worse debt to assets ratio.
2.2 Solvency
CONTX has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.49, CONTX is in line with its industry, outperforming 60.00% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.07, CONTX is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.08%
2.3 Liquidity
A Current Ratio of 4.12 indicates that CONTX has no problem at all paying its short term obligations.
CONTX has a better Current ratio (4.12) than 90.00% of its industry peers.
A Quick Ratio of 4.07 indicates that CONTX has no problem at all paying its short term obligations.
The Quick ratio of CONTX (4.07) is better than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.32% over the past year.
The Earnings Per Share has been growing by 40.02% on average over the past years. This is a very strong growth
The Revenue has grown by 12.19% in the past year. This is quite good.
CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.78% yearly.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
3.2 Future
CONTX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -13.34% yearly.
Based on estimates for the next years, CONTX will show a decrease in Revenue. The Revenue will decrease by -1.19% on average per year.
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.22, the valuation of CONTX can be described as reasonable.
CONTX's Price/Earnings ratio is rather cheap when compared to the industry. CONTX is cheaper than 100.00% of the companies in the same industry.
CONTX is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for CONTX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.22 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CONTX is valued a bit more expensive than 60.00% of the companies in the same industry.
CONTX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.98 | ||
| EV/EBITDA | 12.45 |
4.3 Compensation for Growth
CONTX has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CONTX's earnings are expected to decrease with -35.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.06, CONTX pays a better dividend. On top of this CONTX pays more dividend than 90.00% of the companies listed in the same industry.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
OSL:CONTX (12/30/2025, 7:00:00 PM)
4.24
-0.1 (-2.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap328.05M
Revenue(TTM)132.19M
Net Income(TTM)9.36M
Analysts40
Price Target4.08 (-3.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.52%
Revenue NY rev (3m)-11.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.22 | ||
| Fwd PE | N/A | ||
| P/S | 2.52 | ||
| P/FCF | 50.98 | ||
| P/OCF | 21.99 | ||
| P/B | 3.28 | ||
| P/tB | 3.38 | ||
| EV/EBITDA | 12.45 |
EPS(TTM)0.46
EY10.85%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.08
FCFY1.96%
OCF(TTM)0.19
OCFY4.55%
SpS1.69
BVpS1.29
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.08%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.
What is the valuation status for CONTX stock?
ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.
What is the profitability of CONTX stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.
What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.
What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -28.88% in the next year.